337 related articles for article (PubMed ID: 31113863)
1. Control of p53-dependent transcription and enhancer activity by the p53 family member p63.
Karsli Uzunbas G; Ahmed F; Sammons MA
J Biol Chem; 2019 Jul; 294(27):10720-10736. PubMed ID: 31113863
[TBL] [Abstract][Full Text] [Related]
2. TP53 engagement with the genome occurs in distinct local chromatin environments via pioneer factor activity.
Sammons MA; Zhu J; Drake AM; Berger SL
Genome Res; 2015 Feb; 25(2):179-88. PubMed ID: 25391375
[TBL] [Abstract][Full Text] [Related]
3. Mutant p63 Affects Epidermal Cell Identity through Rewiring the Enhancer Landscape.
Qu J; Tanis SEJ; Smits JPH; Kouwenhoven EN; Oti M; van den Bogaard EH; Logie C; Stunnenberg HG; van Bokhoven H; Mulder KW; Zhou H
Cell Rep; 2018 Dec; 25(12):3490-3503.e4. PubMed ID: 30566872
[TBL] [Abstract][Full Text] [Related]
4. p53 regulates enhancer accessibility and activity in response to DNA damage.
Younger ST; Rinn JL
Nucleic Acids Res; 2017 Sep; 45(17):9889-9900. PubMed ID: 28973438
[TBL] [Abstract][Full Text] [Related]
5. An autoregulatory loop directs the tissue-specific expression of p63 through a long-range evolutionarily conserved enhancer.
Antonini D; Rossi B; Han R; Minichiello A; Di Palma T; Corrado M; Banfi S; Zannini M; Brissette JL; Missero C
Mol Cell Biol; 2006 Apr; 26(8):3308-18. PubMed ID: 16581802
[TBL] [Abstract][Full Text] [Related]
6. The retinal dehydrogenase/reductase retSDR1/DHRS3 gene is activated by p53 and p63 but not by mutants derived from tumors or EEC/ADULT malformation syndromes.
Kirschner RD; Rother K; Müller GA; Engeland K
Cell Cycle; 2010 Jun; 9(11):2177-88. PubMed ID: 20543567
[TBL] [Abstract][Full Text] [Related]
7. Regulation of the Activity in the p53 Family Depends on the Organization of the Transactivation Domain.
Krauskopf K; Gebel J; Kazemi S; Tuppi M; Löhr F; Schäfer B; Koch J; Güntert P; Dötsch V; Kehrloesser S
Structure; 2018 Aug; 26(8):1091-1100.e4. PubMed ID: 30099987
[TBL] [Abstract][Full Text] [Related]
8. Mutant p53 regulates enhancer-associated H3K4 monomethylation through interactions with the methyltransferase MLL4.
Rahnamoun H; Hong J; Sun Z; Lee J; Lu H; Lauberth SM
J Biol Chem; 2018 Aug; 293(34):13234-13246. PubMed ID: 29954944
[TBL] [Abstract][Full Text] [Related]
9. iASPP inhibits p53-independent apoptosis by inhibiting transcriptional activity of p63/p73 on promoters of proapoptotic genes.
Cai Y; Qiu S; Gao X; Gu SZ; Liu ZJ
Apoptosis; 2012 Aug; 17(8):777-83. PubMed ID: 22538442
[TBL] [Abstract][Full Text] [Related]
10. Role of chromatin and transcriptional co-regulators in mediating p63-genome interactions in keratinocytes.
Sethi I; Sinha S; Buck MJ
BMC Genomics; 2014 Nov; 15(1):1042. PubMed ID: 25433490
[TBL] [Abstract][Full Text] [Related]
11. C-terminal α Domain of p63 Binds to p300 to Coactivate β-Catenin.
Katoh I; Maehata Y; Moriishi K; Hata RI; Kurata SI
Neoplasia; 2019 May; 21(5):494-503. PubMed ID: 30986748
[TBL] [Abstract][Full Text] [Related]
12. A half-site of the p53-binding site on the keratin 14 promoter is specifically activated by p63.
Cai BH; Chao CF; Lu MH; Lin HC; Chen JY
J Biochem; 2012 Jul; 152(1):99-110. PubMed ID: 22577164
[TBL] [Abstract][Full Text] [Related]
13. RNAs interact with BRD4 to promote enhanced chromatin engagement and transcription activation.
Rahnamoun H; Lee J; Sun Z; Lu H; Ramsey KM; Komives EA; Lauberth SM
Nat Struct Mol Biol; 2018 Aug; 25(8):687-697. PubMed ID: 30076409
[TBL] [Abstract][Full Text] [Related]
14. Gain-of-function p53 mutants have widespread genomic locations partially overlapping with p63.
Martynova E; Pozzi S; Basile V; Dolfini D; Zambelli F; Imbriano C; Pavesi G; Mantovani R
Oncotarget; 2012 Feb; 3(2):132-43. PubMed ID: 22361592
[TBL] [Abstract][Full Text] [Related]
15. Transcription factor p63 bookmarks and regulates dynamic enhancers during epidermal differentiation.
Kouwenhoven EN; Oti M; Niehues H; van Heeringen SJ; Schalkwijk J; Stunnenberg HG; van Bokhoven H; Zhou H
EMBO Rep; 2015 Jul; 16(7):863-78. PubMed ID: 26034101
[TBL] [Abstract][Full Text] [Related]
16. Differential recognition of response elements determines target gene specificity for p53 and p63.
Osada M; Park HL; Nagakawa Y; Yamashita K; Fomenkov A; Kim MS; Wu G; Nomoto S; Trink B; Sidransky D
Mol Cell Biol; 2005 Jul; 25(14):6077-89. PubMed ID: 15988020
[TBL] [Abstract][Full Text] [Related]
17. Dissecting the DNA binding landscape and gene regulatory network of p63 and p53.
Riege K; Kretzmer H; Sahm A; McDade SS; Hoffmann S; Fischer M
Elife; 2020 Dec; 9():. PubMed ID: 33263276
[TBL] [Abstract][Full Text] [Related]
18. Repression of p63 and induction of EMT by mutant Ras in mammary epithelial cells.
Yoh KE; Regunath K; Guzman A; Lee SM; Pfister NT; Akanni O; Kaufman LJ; Prives C; Prywes R
Proc Natl Acad Sci U S A; 2016 Oct; 113(41):E6107-E6116. PubMed ID: 27681615
[TBL] [Abstract][Full Text] [Related]
19. TAp63gamma can substitute for p53 in inducing expression of the maspin tumor suppressor.
Spiesbach K; Tannapfel A; Mössner J; Engeland K
Int J Cancer; 2005 Apr; 114(4):555-62. PubMed ID: 15578720
[TBL] [Abstract][Full Text] [Related]
20. REDD1, a developmentally regulated transcriptional target of p63 and p53, links p63 to regulation of reactive oxygen species.
Ellisen LW; Ramsayer KD; Johannessen CM; Yang A; Beppu H; Minda K; Oliner JD; McKeon F; Haber DA
Mol Cell; 2002 Nov; 10(5):995-1005. PubMed ID: 12453409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
